The Healthcare Cannabis Weekly Critique & Newsletter: Cannabis for Vision, THC Levels Escalating, Fibromyalgia Misdiagnosed, and much more

[ad_1]

1 of the most typically sited makes use of for healthcare cannabis is eye well being, namely glaucoma. But does it really operate?

As it turns out, the science behind that healthcare claim is, at greatest, promising but not concrete. Also, did you know that the levels of THC in European cannabis has doubled more than the final 10 years? And have you heard how normally fibromyalgia sufferers are misdiagnosed? All that and much more in this week’s Healthcare Cannabis Weekly Critique and Newsletter.

As usually, you can get our weekly digest straight to your inbox, by subscribing to our weekly newsletter, under:

FEATURED STORY: Cannabis To Combat Vision-Connected Issues: Does It In fact Function?

Eyes are the window to the soul, the lamp to the physique, and our personal private portals to the outdoors planet. While we do not actively believe about the approach of “seeing”, it is one thing we do from the moment we open our eyes at birth. And it is one thing that is readily noticed (and especially worrisome) when there is some sort of visionary malfunction.

Vision problems, like glaucoma, are amongst of the most widespread makes use of for healthcare cannabis and was when a situation that had federal government approval for “compassionate marijuana use”. But is there any science to back up this claim? Let’s take a appear.

Click right here to study the complete story

Subscribe to the Healthcare Cannabis Weekly Newsletter


Have to Study Articles:

CiiTech Entrepreneur, “The Numbers Do not Stack Up For Healthcare Cannabis”

medical cannabis

Outspoken Israel entrepreneur Clifton Flack has lost faith in healthcare cannabis and believes the future is CBD. Speaking at the Hemp &amp CBD Expo at Birmingham, England, he told CBD Testers: “The numbers do not stack up for healthcare cannabis.

Click right here to study the complete story 

Subscribe to the Healthcare Cannabis Weekly Newsletter

European Cannabis THC Levels Have Doubled In Ten Years

cannabis potency

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) report shows that the THC concentration of ‘herbal cannabis’ doubled from five% to 10%, from 2006 to 2016, while cannabis resin potency enhanced from eight% to 17% more than the similar period.

Click right here to study the complete story 

Subscribe to the Healthcare Cannabis Weekly Newsletter

How Typically Are Fibromyalgia Individuals Misdiagnosed?

fibromyalgia

According to a new study from Arthritis Care &amp Analysis, the agreement amongst physicians’ diagnosis of fibromyalgia and the published criteria is only moderate. The study stated that, in total, physicians incorrectly identified 11.four % of sufferers who had been criteria-adverse and failed to diagnose 49.six % of criteria-good sufferers. 

Click right here to study the complete story 

Subscribe to the Healthcare Cannabis Weekly Newsletter

Other Trending News:

[ad_2]

Latest posts